Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

VNRX stock hub

VolitionRx Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

VNRXis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.8M

NYSEAMERICAN

Market data

Live price

Current market quote for this ticker.

Current price

VNRX

In the news

Latest news · VNRX

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROEn/a

P25 -105.6P50 -46.5P75 -3.1

ROICn/a

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All VNRX market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

USD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0000093314
Company name	VolitionRx Limited
Country	United States
Country code	US
Cusip	928661206
Employees	75
Employees Change	-21%
Employees Change Percent	-21.88
Enterprise value	$28.2M
Exchange	NYSEAMERICAN
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
Isin	US9286612067
Last refreshed	2026-05-10
Market cap	$17.8M
Market cap category	Nano-Cap
Price	$2.25
Price currency	USD
Rev Per Employee	23,031.79x
Sector	Healthcare
Sic	2835
Symbol	VNRX
Website	https://volition.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-131%
EV Sales Forward	11.84x
EV/Sales	16.31x
FCF yield	-110.9%
P/S ratio	10.32x
PS Forward	7.49x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross margin	100%
Gross Profit	$1.7M
Gross Profit Growth	40.04%
Gross Profit Growth Q	133.25%
Gross Profit Growth3 Y	77.98%
Gross Profit Growth5 Y	164.15%
Net Income	$-23.4M
Net Income Growth Years	2%
Pretax Margin	-1,360.63%
Profit Per Employee	$-311,427
ROA	-166.7
Roa5y	-101.4
ROCE	407.9

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-28.54%
Cagr1y	-78.37%
Cagr3y	-61.68%
Cagr5y	-48.55%
EPS Growth Quarters	10
EPS Growth Years	3
Revenue Growth	40.04x
Revenue Growth Q	133.25x
Revenue Growth Quarters	4x
Revenue Growth Years	5x
Revenue Growth3 Y	77.98x
Revenue Growth5 Y	164.15x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.21
Assets	$6.9M
Cash	$1.1M
Current Assets	$2.1M
Current Liabilities	$12.2M
Debt	$11.5M
Equity	$-35.6M
Interest Coverage	-8.73
Liabilities	$42.5M
Long Term Assets	$4.8M
Long Term Liabilities	$30.3M
Net Cash	$-10.3M
Net Cash By Market Cap	$-58.04
Tangible Book Value	$-34.6M
Tangible Book Value Per Share	$-5.5
WACC	12.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	0.17
Net Working Capital	$-7.7M
Quick ratio	0.12
Working Capital	$-10.2M
Working Capital Turnover	$-0.25

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-23.46%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-96.53%
1Y total return	-78.34%
200-day SMA	7.43
3Y total return	-94.38%
50-day SMA	3.45
50-day SMA vs 200-day SMA	50under200
5Y total return	-96.39%
All Time High	185.6
All Time High Change	-98.79%
All Time High Date	2014-09-22
All Time Low	2.17
All Time Low Change	3.69%
All Time Low Date	2026-05-05
ATR	0.29
Beta	1.03
Beta1y	0.19
Beta2y	0.29
Ch YTD	-55.99
High	2.45
High52	18.8
High52 Date	2025-06-23
High52ch	-88.03%
Low	2.25
Low52	2.17
Low52 Date	2026-05-05
Low52ch	3.69%
Ma50ch	-34.74%
Premarket Change Percent	0.83
Premarket Price	$2.44
Premarket Volume	2,725
Price vs 200-day SMA	-69.71%
RSI	27.12
RSI Monthly	30.48
RSI Weekly	26.85
Sharpe ratio	-1.21x
Sortino ratio	-1.82
Total Return	-23.46%
Tr YTD	-55.99
Tr1m	-33%
Tr1w	-7.41%
Tr3m	-54.27%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Ratings	Strong Buy
Earnings EPS Estimate	$-0.73
Earnings Revenue Estimate	425,936x
Earnings Revenue Estimate Growth	72.87x
Operating Income	$-21.7M
Operating margin	-1,258.5
Price target	$33.33
Price Target Change	$1,381

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	6,880,428%
Float Percent	86.83%
Net Borrowing	6,021,439
Shares Insiders	4.94%
Shares Institutions	15.31%
Shares Out	7,924,062
Shares Qo Q	11.8%
Shares Yo Y	23.46%
Short Float	5.15%
Short Ratio	0.25
Short Shares	4.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-21.5M
Average Volume	243,177.05x
Bv Per Share	-5.45
CAPEX	$-89,558
Ch10y	-96.53
Ch1m	-33
Ch1w	-7.41
Ch1y	-78.34
Ch3m	-54.27
Ch3y	-94.38
Ch5y	-96.39
Ch6m	-71.23
Change	-7.02%
Change From Open	-6.25
Close	2.42
Days Gap	-0.83
Depreciation Amortization	983,706
Dollar Volume	387,769.5
Earnings Date	2026-05-12
Earnings Time	amc
EBIT	$-21.7M
EBITDA	$-20.8M
EPS	$-4.37
F Score	2
FCF	$-19.8M
FCF EV Yield	-70.17x
FCF Per Share	$-2.5
Financing CF	17,092,858
Fiscal Year End	December
Investing CF	-89,558
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-31
Last Report Date	2025-12-31
Last Split Date	2026-04-28
Last Split Type	Reverse
Last10k Filing Date	2026-03-31
Ma150	5.56
Ma150ch	-59.55%
Ma20	2.86
Ma20ch	-21.41%
Net CF	-2,147,401
Next Earnings Date	2026-05-22
Open	2.4
Optionable	Yes
Position In Range	0
Post Close	2.25
Postmarket Change Percent	4
Postmarket Price	$2.34
Ppne	4,523,598
Pre Close	2.42
Price Date	2026-05-08
Relative Volume	0.71x
Revenue	1,727,384x
SBC By Revenue	100.71x
Share Based Comp	1,739,711
Tr6m	-71.23%
Us State	Nevada
Volume	172,342
Z Score	-62.41

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does VNRX pay a dividend?

Capital-return profile for this ticker.

Performance

VNRX stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns VNRX?

Insider, institutional, and short-interest positioning.

Institutional ownership

+15.3%

Float: +86.8% of shares outstanding

Insider ownership

+4.9%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

VNRX momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

27.1

Below 30: short-term oversold

Price vs 200-day MA

-69.7%

50/200-day relationship not available

Beta (5Y)

1.03

Moves roughly with the market

Sharpe ratio

-1.21

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About VNRX

Hub-level FAQ points readers to the deeper analysis pages.

What is the current VNRX stock rating?

VolitionRx Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full VNRX analysis?

The full report lives at /stocks/VNRX/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for VNRX?

The latest report frames VNRX around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the VNRX page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.